Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) EBT Margin: 2020-2024

Historic EBT Margin for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -26.03%.

  • Journey Medical's EBT Margin rose 321.00% to -13.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -14.38%, marking a year-over-year increase of 1714.00%. This contributed to the annual value of -26.03% for FY2024, which is 2144.00% down from last year.
  • Per Journey Medical's latest filing, its EBT Margin stood at -26.03% for FY2024, which was down 467.45% from -4.59% recorded in FY2023.
  • Journey Medical's EBT Margin's 5-year high stood at 16.06% during FY2020, with a 5-year trough of -67.10% in FY2021.
  • Moreover, its 3-year median value for EBT Margin was -26.03% (2024), whereas its average is -23.58%.
  • Per our database at Business Quant, Journey Medical's EBT Margin tumbled by 8,316bps in 2021 and then spiked by 3,555bps in 2023.
  • Yearly analysis of 5 years shows Journey Medical's EBT Margin stood at 16.06% in 2020, then plummeted by 8,316bps to -67.10% in 2021, then skyrocketed by 2,696bps to -40.13% in 2022, then spiked by 3,555bps to -4.59% in 2023, then tumbled by 2,144bps to -26.03% in 2024.